Early Warning Scores in Pregnant Woman

Not Applicable

Completed

• Conditions: Pregnancy Complications
• Interventions: Other: All patients who were pregnant and underwent cesarean section

• Registration Number: NCT06488690
• Lead Sponsor: Suleyman Demirel University

Brief Summary

Our study aims to evaluate the use of early warning scores as a screening tool to predict obstetric mortality and morbidity in pregnant women who will undergo cesarean section.

Detailed Description

Our study aims to evaluate the use of early warning scores as a screening tool to predict obstetric mortality and morbidity in pregnant women who will undergo cesarean section.

This prospective study included 304 patients undergoing cesarean section at Suleyman Demirel University between April 2022 and April 2023. Physiological parameters were assessed in all 304 pregnant women before the operation. Maternal early warning scores, including modified early obstetric warning score (MEOWS), maternal early warning score (MEWC), and maternal early warning triggers (MEWT), were calculated for each patient. Patients triggering the system were classified as Group 1 (risky patients), while those not triggering the system were classified as Group 2 (risk-free patients).

Study Timeline

• Study Start: 2022-04-01
• Primary Completion: 2023-04-01
• Study Completion: 2024-02-01
• Study First Submitted: 2024-06-27
• Status Verified: 2024-07
• Study First Submitted QC: 2024-07-03
• Last Update Submitted: 2024-07-03
• Study First Posted: 2024-07-05
• Last Update Posted: 2024-07-05

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 304

Inclusion Criteria

• All patients who are pregnant and undergo cesarean section

Exclusion Criteria

• None

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SEQUENTIAL

Arm && Interventions

Group	Intervention	Description
All patients who are pregnant and undergo cesarean section	All patients who were pregnant and underwent cesarean section	We included all patients who were pregnant and underwent cesarean section and calculated maternal early warning scores.

Primary Outcome Measures

Name	Time	Method
MEWT score	One year	For MEWT, the presence of a "trigger" defined as either a single severely abnormal parameter (falling in the "red" zone) or two mildly abnormal parameters (falling in the "yellow" zone) was categorized as the risky group, with the absence or mildness of the trigger considered as the risk-free group.
MEOWS, MEWC and MEWT scores	One year	The presence of a "trigger" for MEOWS in all systems, defined as either a single severely abnormal parameter (falling in the "red" zone) or two slightly abnormal parameters (falling in the "yellow" zone), was categorized as the risky group. Absence or mildness of the trigger was considered as the risk-free group.
MEWC score	One year	In the case of MEWC, the presence of only one abnormal parameter designated the risk group, while the absence of a trigger indicated the risk-free group.

Secondary Outcome Measures

Name	Time	Method
APGAR score	One year	APGAR scores at 1st and 5th minutes were calculated for postnatal babies.
Aldrete score	One year	The Modified Aldrete Recovery Score System was computed for mothers to assess postoperative recovery.
Glasgow Coma Scale	One year	The Glasgow Coma Scale (GCS) was used to evaluate the consciousness of pregnant women.

Trial Locations

Locations (1)

Suleyman Demirel University; 🇹🇷 Isparta, Merkez, Turkey